SCGN
From Wikipedia, the free encyclopedia
|
Secretagogin, EF-hand calcium binding protein
|
||||||||||||||
| Identifiers | ||||||||||||||
| Symbol(s) | SCGN; CALBL; DJ501N12.8; SECRET; SEGN; setagin | |||||||||||||
| External IDs | OMIM: 609202 MGI: 2384873 HomoloGene: 5088 | |||||||||||||
|
||||||||||||||
| RNA expression pattern | ||||||||||||||
| Orthologs | ||||||||||||||
| Human | Mouse | |||||||||||||
| Entrez | 10590 | 214189 | ||||||||||||
| Ensembl | ENSG00000079689 | ENSMUSG00000021337 | ||||||||||||
| Uniprot | O76038 | Q5NCL7 | ||||||||||||
| Refseq | NM_006998 (mRNA) NP_008929 (protein) |
NM_145399 (mRNA) NP_663374 (protein) |
||||||||||||
| Location | Chr 6: 25.76 - 25.81 Mb | Chr 13: 23.96 - 24 Mb | ||||||||||||
| Pubmed search | [1] | [2] | ||||||||||||
Secretagogin, EF-hand calcium binding protein, also known as SCGN, is a human gene.[1]
The encoded protein is a secreted calcium-binding protein which is found in the cytoplasm. It is related to calbindin D-28K and calretinin. This protein is thought to be involved in KCL-stimulated calcium flux and cell proliferation.[1]
[edit] References
[edit] Further reading
- Wagner L, Oliyarnyk O, Gartner W, et al. (2000). "Cloning and expression of secretagogin, a novel neuroendocrine- and pancreatic islet of Langerhans-specific Ca2+-binding protein.". J. Biol. Chem. 275 (32): 24740-51. doi:. PMID 10811645.
- Gartner W, Lang W, Leutmetzer F, et al. (2002). "Cerebral expression and serum detectability of secretagogin, a recently cloned EF-hand Ca(2+)-binding protein.". Cereb. Cortex 11 (12): 1161-9. PMID 11709487.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899-903. doi:. PMID 12477932.
- Mungall AJ, Palmer SA, Sims SK, et al. (2003). "The DNA sequence and analysis of human chromosome 6.". Nature 425 (6960): 805-11. doi:. PMID 14574404.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40-5. doi:. PMID 14702039.
- Zhan X, Evans CO, Oyesiku NM, Desiderio DM (2004). "Proteomics and transcriptomics analyses of secretagogin down-regulation in human non-functional pituitary adenomas.". Pituitary 6 (4): 189-202. PMID 15237930.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121-7. doi:. PMID 15489334.
- Zierhut B, Daneva T, Gartner W, et al. (2005). "Setagin and secretagogin-R22: Posttranscriptional modification products of the secretagogin gene.". Biochem. Biophys. Res. Commun. 329 (4): 1193-9. doi:. PMID 15766553.
- Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network.". Nature 437 (7062): 1173-8. doi:. PMID 16189514.
- Skovhus KV, Bergholdt R, Erichsen C, et al. (2007). "Identification and characterization of secretagogin promoter activity.". Scand. J. Immunol. 64 (6): 639-45. doi:. PMID 17083620.

